Interference of diabetes on the association of γ-glutamyl transpeptidase to platelet ratio with liver fibrosis in chronic hepatitis C by Chung-Feng Huang

Get full text

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy by Chung-Feng Huang, Ming-Lung Yu

Get full text

Chronic hepatitis C infection in the elderly by Chung-Feng Huang, Wan-Long Chuang, Ming-Lung Yu

Get full text

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma by Chia-I. Lin, Zu-Yau Lin, Ming-Yen Hsieh, Chung-Feng Huang, Su-Hwei Chen, Wan-Long Chuang

Get full text

The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments by Phumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu, Shu-Chi Wang

Get full text

Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021 by Tyng-Yuan Jang, Hsin-Hui Wang, Chung-Feng Huang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Cheng-Yu Kuo, Ming-Lung Yu

Get full text

The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan by Keva Joseph, Ciniso Sylvester Shabangu, Tyng-Yuan Jang, Chung-Feng Huang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu, Shu-Chi Wang

Get full text

The compound annual growth rate of the fibrosis‐4 index in chronic hepatitis B patients by Ta‐Wei Liu, Chung‐Feng Huang, Pei‐Chien Tsai, Ming‐Lun Yeh, Tyng‐Yuan Jang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang

Get full text

Dose Consideration of Lenvatinib’s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy by Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, Po-Yao Hsu, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang

Get full text

Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma by Zu‐Yau Lin, Ming‐Lun Yeh, Ching‐I Huang, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang

Get full text

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index by Chung-Feng Huang, Ming-Lun Yeh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Ta-Wei Liu, Pei-Chien Tsai, Tyng-Yuan Jang

Get full text

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma. by Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Zu-Yau Lin, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Shinn-Cherng Chen, Wan-Long Chuang

Get full text

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma by Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Lung Yu, Wan-Long Chuang

Get full text

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognos- tic factor in hepatitis C virus-related hepatocellular carcinoma by Ching-Chih Lin, Ta-Wei Liu, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang, Chia-Yen Dai, Ming-Lung Yu

Get full text

Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection by Chung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, Jee-Fu Huang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Lung Yu, Chia-Yen Dai, Wan-Long Chuang

Get full text

Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analog... by Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Shu-Fen Liu, Hua-Ling Yang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu

Get full text

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies by Chien-Tzu Huang, Ching-Ping Lee, Tzu-Yin Chen, Yi-Chang Liu, Shih-Feng Cho, Jeng-Shiun Du, Ming-Lung Yu, Chung-Feng Huang, Sheng-Fan Wang, Hui-Hua Hsiao

Get full text

Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆ by Ming-Lun Yeh, Po-Cheng Liang, Sam Trinh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Mindie H. Nguyen, Ming-Lung Yu

Get full text

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection by Ta-Ya Lin, Ming-Lun Yeh, Ching-I Huang, Yao-Li Chen, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Ming-Lung Yu, Wan-Long Chuang

Get full text

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients. by Ming-Lun Yeh, Cheng-Yuan Peng, Chia-Yen Dai, Hsueh-Chou Lai, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Lung Yu, Wan-Long Chuang

Get full text